Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Lin, S-K
Chen, C-K
Ball, D
Liu, H-C
and
Loh, E-W
2003.
Gender-specific contribution of the GABAA subunit genes on 5q33 in methamphetamine use disorder.
The Pharmacogenomics Journal,
Vol. 3,
Issue. 6,
p.
349.
LIN, SHIH‐KU
BALL, DAVID
HSIAO, CHENG‐CHENG
CHIANG, YUAN‐LIN
REE, SHAO‐CHUN
and
CHEN, CHIH‐KEN
2004.
Psychiatric comorbidity and gender differences of persons incarcerated for methamphetamine abuse in Taiwan.
Psychiatry and Clinical Neurosciences,
Vol. 58,
Issue. 2,
p.
206.
Chen, Chih-Ken
and
Murray, Robin M.
2004.
Neurodevelopment and Schizophrenia.
p.
248.
Walterfang, Mark
Upjohn, Edward
and
Velakoulis, Dennis
2005.
Is Schizophrenia Associated with Narcolepsy?.
Cognitive and Behavioral Neurology,
Vol. 18,
Issue. 2,
p.
113.
Maxwell, Jane Carlisle
2005.
Emerging research on methamphetamine.
Current Opinion in Psychiatry,
Vol. 18,
Issue. 3,
p.
235.
Dean, Kimberlie
and
Murray, Robin M.
2005.
Environmental risk factors for psychosis.
Dialogues in Clinical Neuroscience,
Vol. 7,
Issue. 1,
p.
69.
O'Daly, Owen G.
Guillin, Olivier
Tsapakis, Eva-Maria
Martinez, Diana
Shergill, Sukhwinder S.
Murray, Robin M.
and
Buckley, Peter F.
2005.
Schizophrenia and Substance Abuse Co-Morbidity.
Journal of Dual Diagnosis,
Vol. 1,
Issue. 2,
p.
11.
Meredith, Charles W.
Jaffe, Craig
Ang-Lee, Kathleen
and
Saxon, Andrew J.
2005.
Implications of Chronic Methamphetamine Use: A Literature Review.
Harvard Review of Psychiatry,
Vol. 13,
Issue. 3,
p.
141.
Chen, Chih-Ken
Lin, Shih-Ku
Sham, Pak C.
Ball, David
Loh, El-Wui
and
Murray, Robin M.
2005.
Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis.
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics,
Vol. 136B,
Issue. 1,
p.
87.
Tenn, Catherine C.
Fletcher, Paul J.
and
Kapur, Shitij
2005.
A putative animal model of the “prodromal” state of schizophrenia.
Biological Psychiatry,
Vol. 57,
Issue. 6,
p.
586.
Broome, Matthew R.
Woolley, James B.
Tabraham, Paul
Johns, Louise C.
Bramon, Elvira
Murray, Graham K.
Pariante, Carmine
McGuire, Philip K.
and
Murray, Robin M.
2005.
What causes the onset of psychosis?.
Schizophrenia Research,
Vol. 79,
Issue. 1,
p.
23.
Os, Jim van
Krabbendam, Lydia
Myin-Germeys, Inez
and
Delespaul, Philippe
2005.
The schizophrenia envirome.
Current Opinion in Psychiatry,
Vol. 18,
Issue. 2,
p.
141.
Tanner-Smith, Emily E.
2006.
Pharmacological content of tablets sold as “ecstasy”: Results from an online testing service.
Drug and Alcohol Dependence,
Vol. 83,
Issue. 3,
p.
247.
Sheridan, Janie
Bennett, Sara
Coggan, Carolyn
Wheeler, Amanda
and
McMillan, Karen
2006.
Injury associated with methamphetamine use: A review of the literature.
Harm Reduction Journal,
Vol. 3,
Issue. 1,
Schuckit, Marc A.
2006.
Comorbidity between substance use disorders and psychiatric conditions.
Addiction,
Vol. 101,
Issue. s1,
p.
76.
2006.
Drug and Alcohol Abuse.
p.
137.
MIURA, HIDEKI
FUJIKI, MASUMI
SHIBATA, ARIHIRO
and
ISHIKAWA, KENJI
2006.
Prevalence and profile of methamphetamine users in adolescents at a juvenile classification home.
Psychiatry and Clinical Neurosciences,
Vol. 60,
Issue. 3,
p.
352.
AKIYAMA, KAZUFUMI
2006.
Longitudinal Clinical Course Following Pharmacological Treatment of Methamphetamine Psychosis Which Persists after Long‐Term Abstinence.
Annals of the New York Academy of Sciences,
Vol. 1074,
Issue. 1,
p.
125.
PERRON, BRIAN
and
MUNSON, MICHELLE
2006.
Coping with Voices: A Group Approach for Managing Auditory Hallucinations.
American Journal of Psychiatric Rehabilitation,
Vol. 9,
Issue. 3,
p.
241.
McKetin, Rebecca
McLaren, Jennifer
Lubman, Dan I.
and
Hides, Leanne
2006.
The prevalence of psychotic symptoms among methamphetamine users.
Addiction,
Vol. 101,
Issue. 10,
p.
1473.